Who is sponsoring NCT00676065?

NCT00676065 is sponsored by Center for Epidemiology and Health Research, Germany.

What condition does NCT00676065 study?

NCT00676065 studies Arterial Thromboembolism, Venous Thromboembolism, Breast Cancer.

What is the status of NCT00676065?

NCT00676065 is currently COMPLETED.

Last reviewed 2014-11-13 · How we verify

Long-term Active Surveillance Study for Oral Contraceptives (LASS)

NCT00676065 COMPLETED Results posted

The objective of this study is to characterize and compare the risks of long-term use of oral contraceptives containing drospirenone and of other established oral contraceptives.

Details

Lead sponsor	Center for Epidemiology and Health Research, Germany
Status	COMPLETED
Enrolment	58303
Start date	2001-02
Completion	2011-12

Conditions

Arterial Thromboembolism
Venous Thromboembolism
Breast Cancer

Primary outcomes

Arterial Thromboembolism — Within 10 years
Arterial thromboembolism associated with the use of oral contraceptives containing drospirenone or levonorgestrel or other progestogens.
Venous Thromboembolism — Within 10 years
Venous thromboembolism associated with the use of oral contraceptives containing drospirenone or levonorgestrel or other progestogens.
Breast Cancer — Within 10 years
Breast cancer associated with the use of hormonal contraceptives either containing both drospirenone (DRSP) and ethinylestradiol (EE), levonorgestrel (LNG) or any other hormonal contraceptive without DRSP.

Countries

Germany